SteadyMed Ltd. Fund Company Profile

Description

SteadyMed Ltd., together with its subsidiaries, operates as a specialty pharmaceutical company that focuses on the development and commercialization of drug product candidates for the treatment of orphan and other diseases with unmet parenteral delivery needs. It engages in developing Trevyent for the treatment of pulmonary arterial hypertension. The company also develops two products for the treatment of post-surgical and acute pain in the home setting, which include ketorolac PatchPump for short-term management of moderately severe acute pain; and bupivacaine PatchPump for local anesthesia post-surgery. Its product candidates are enabled by its proprietary PatchPump, a disposable drug administration technology that is aseptically prefilled with liquid drug at the site of manufacture and pre-programmed to deliver an accurate, steady flow of drug to a patient, either subcutaneously or intravenously. SteadyMed Ltd. was founded in 2005 and is headquartered in San Ramon, California.